Forxiga HF General Drug Use-Results Study
NCT04865406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1221
Last updated 2025-07-03
Summary
To capture safety when Forxiga is administered to patients with HF in clinical practice after launch.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-10
- Primary Completion
- 2024-08-22
- Completion
- 2024-08-22
Countries
- Japan
Study Locations
More Related Trials
-
Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure
NCT03292653 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%
NCT04986202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction
NCT04836182 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
NCT05971732 ·Status: UNKNOWN ·Phase: PHASE4
-
Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation
NCT06759909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
NCT06435156 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction
NCT06615674 ·Status: COMPLETED ·Phase: PHASE4
-
A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants
NCT05044325 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
NCT04216342 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
NCT00742508 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
NCT04083339 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Ertugliflozin in Chronic Heart Failure
NCT04438213 ·Status: RECRUITING ·Phase: PHASE2
-
Tezosentan in Acute Heart Failure
NCT00525707 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.
NCT03756285 ·Status: TERMINATED ·Phase: PHASE2
-
Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)
NCT05164653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
NCT03416270 ·Status: COMPLETED ·Phase: PHASE2
-
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
NCT04564742 ·Status: COMPLETED ·Phase: PHASE3
-
Use of SGLT2i in noHCM With HFpEF
NCT06401343 ·Status: RECRUITING ·Phase: PHASE4
-
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
NCT03619213 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)
NCT05093933 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
NCT07185776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
NCT03388593 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Dapagliflozin on VT in Patients With Heart Failure.
NCT05550441 ·Status: UNKNOWN ·Phase: PHASE4
-
Real-world Dapagliflozin Experience in Patients With Heart Failure in Greece
NCT05635331 ·Status: COMPLETED
-
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271 ·Status: COMPLETED